PSMB1 and bladder transitional cell carcinoma: Similarly, PSMB1, the non-catalytic component of the proteasome complex, was implicated in poor survival outcomes across several cancer types (Fig. 3c), namely bladder urothelial carcinoma (BLCA), BRCA, HNSC and lung adenocarcinoma (LUAD).